sur KLEA HOLDING (isin : FR0013481835)
Klea Pharmaceuticals Launches Operations with a Strategic Partner
Klea Pharmaceuticals, a subsidiary of Klea Holding, is launching operations in the United Arab Emirates with a portfolio of 57 medications. This launch is being carried out in partnership with Al Khayyat Investments (AKI), a major player in pharmaceutical distribution in the Middle East.
Based in Dubai, Klea Pharmaceuticals will benefit from AKI's regional coverage to deploy its products. The partnership offers a strong growth opportunity in the rapidly expanding Middle Eastern and African pharmaceutical market, with projected revenues exceeding €2 million by 2026.
Regulatory procedures and operational structuring are underway, with finalization expected by June 2026. Entry into this market aims to capitalize on strong local demand for health products.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de KLEA HOLDING